Robert Gordon

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

Ronald van Vollenhoven, Bevra H. Hahn, George C. Tsokos et al. · The Lancet · 2018 · 317 citations

Rheumatology, Il-23 Inhibitor, Autoimmune Disease +13

Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant Recipients

Howard J. Eisen, Jon Kobashigawa, Anne Keogh et al. · The Journal of Heart and Lung Transplantation · 2005 · 259 citations

Transplantation, Cardiovascular Disease, Controlled Trial +7

Abdominal Organ Cluster Transplantation for the Treatment of Upper Abdominal Malignancies

Thomas E. Starzl, S Todo, ANDREAS TZAKIS et al. · Annals of Surgery · 1989 · 258 citations · Full text

Orthotopic Liver Transplantation for Alcoholic Liver Disease

Shashi Kumar, Rudolf Stauber, Judith S. Gavaler et al. · Hepatology · 1990 · 234 citations · Full text

Solid Organ Transplantation, Orthotopic Liver Transplantation, United States +19